Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Corrigendum: Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength.

Ebrahimi-Fakhari D, Dillmann U, Flotats-Bastardas M, Poryo M, Abdul-Khaliq H, Shamdeen MG, Mischo B, Zemlin M, Meyer S.

Front Pediatr. 2019 Jul 25;7:284. doi: 10.3389/fped.2019.00284. eCollection 2019.

2.

Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease.

Behnke S, Pilotto A, Liepelt-Scarfone I, Yilmaz R, Pausch C, Dieterich S, Bürmann J, Spiegel J, Dillmann U, Unger M, Posner I, Berg D.

Parkinsonism Relat Disord. 2019 Sep;66:68-73. doi: 10.1016/j.parkreldis.2019.07.005. Epub 2019 Jul 7.

PMID:
31324557
3.

MIBG scintigraphy of the major salivary glands in progressive supranuclear palsy and corticobasal degeneration.

Schubert E, Dogan S, Dillmann U, Schaefer-Schuler A, Fassbender K, Ezziddin S, Spiegel J.

Parkinsonism Relat Disord. 2019 Sep;66:247-248. doi: 10.1016/j.parkreldis.2019.07.003. Epub 2019 Jul 6. No abstract available.

PMID:
31300262
4.

Off-Label Use of Ataluren in Four Non-ambulatory Patients With Nonsense Mutation Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength.

Ebrahimi-Fakhari D, Dillmann U, Flotats-Bastardas M, Poryo M, Abdul-Khaliq H, Shamdeen MG, Mischo B, Zemlin M, Meyer S.

Front Pediatr. 2018 Oct 23;6:316. doi: 10.3389/fped.2018.00316. eCollection 2018. Erratum in: Front Pediatr. 2019 Jul 25;7:284.

5.

MIBG scintigraphy of the major salivary glands in multiple system atrophy.

Soboll L, Leppert D, Dillmann U, Schaefer-Schuler A, Fassbender K, Ezziddin S, Spiegel J.

Parkinsonism Relat Disord. 2018 Aug;53:112-114. doi: 10.1016/j.parkreldis.2018.04.034. Epub 2018 May 4.

PMID:
29752191
6.

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.

Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Bürmann J, Faßbender K, Schäfer KH, Unger MM.

Parkinsonism Relat Disord. 2018 May;50:104-107. doi: 10.1016/j.parkreldis.2018.02.022. Epub 2018 Feb 12.

PMID:
29454662
7.

[Requirements of neurologists for autopsies].

Schulz-Schaeffer WJ, Dillmann U, Faßbender K, Wrede A.

Pathologe. 2017 Sep;38(5):387-393. doi: 10.1007/s00292-017-0336-3. Review. German.

PMID:
28842750
8.

Facial emotion recognition in Parkinson's disease: Association with age and olfaction.

Kalampokini S, Lyros E, Luley M, Schöpe J, Spiegel J, Bürmann J, Dillmann U, Fassbender K, Unger MM.

J Clin Exp Neuropsychol. 2018 Apr;40(3):274-284. doi: 10.1080/13803395.2017.1341470. Epub 2017 Jun 21.

PMID:
28637374
9.

Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's disease.

Haqparwar J, Pepe A, Fassbender K, Dillmann U, Ezziddin S, Schaefer A, Leppert D, Spiegel J.

Parkinsonism Relat Disord. 2017 Jan;34:26-30. doi: 10.1016/j.parkreldis.2016.10.011. Epub 2016 Oct 15.

PMID:
27769648
10.

Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.

Stocchi F, Hsu A, Khanna S, Ellenbogen A, Mahler A, Liang G, Dillmann U, Rubens R, Kell S, Gupta S.

Parkinsonism Relat Disord. 2014 Dec;20(12):1335-40. doi: 10.1016/j.parkreldis.2014.08.004. Epub 2014 Aug 15.

11.

Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.

Isaias IU, Spiegel J, Brumberg J, Cosgrove KP, Marotta G, Oishi N, Higuchi T, Küsters S, Schiller M, Dillmann U, van Dyck CH, Buck A, Herrmann K, Schloegl S, Volkmann J, Lassmann M, Fassbender K, Lorenz R, Samnick S.

Front Aging Neurosci. 2014 Aug 14;6:213. doi: 10.3389/fnagi.2014.00213. eCollection 2014.

12.

Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.

Lorenz R, Samnick S, Dillmann U, Schiller M, Ong MF, Faßbender K, Buck A, Spiegel J.

Acta Neurol Scand. 2014 Sep;130(3):164-71. doi: 10.1111/ane.12259. Epub 2014 Apr 25.

PMID:
24762290
13.

Principal Component Analysis of gait in Parkinson's disease: relevance of gait velocity.

Dillmann U, Holzhoffer C, Johann Y, Bechtel S, Gräber S, Massing C, Spiegel J, Behnke S, Bürmann J, Louis AK.

Gait Posture. 2014 Mar;39(3):882-7. doi: 10.1016/j.gaitpost.2013.11.021. Epub 2013 Dec 10.

PMID:
24374062
14.

Performance of repetitive alternating elbow movements in Parkinson's disease.

Spiegel J, Uhrig I, Krick C, Behnke S, Fassbender K, Dillmann U.

Eur Neurol. 2014;71(1-2):84-8. doi: 10.1159/000354677. Epub 2013 Dec 5.

PMID:
24335107
15.

Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?

Guidez D, Behnke S, Halmer R, Dillmann U, Faßbender K, Kirsch CM, Hellwig D, Spiegel J.

J Neurol. 2014 Jan;261(1):45-51. doi: 10.1007/s00415-013-7135-4. Epub 2013 Oct 18.

PMID:
24136584
16.

Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson's disease.

Behnke S, Hellwig D, Bürmann J, Runkel A, Farmakis G, Kirsch CM, Fassbender K, Becker G, Dillmann U, Spiegel J.

Parkinsonism Relat Disord. 2013 Nov;19(11):995-9. doi: 10.1016/j.parkreldis.2013.06.019. Epub 2013 Jul 21.

PMID:
23880025
17.

Novel FHL1 mutation in a family with reducing body myopathy.

Schreckenbach T, Henn W, Kress W, Roos A, Maschke M, Feiden W, Dillmann U, Schulz JB, Weis J, Claeys KG.

Muscle Nerve. 2013 Jan;47(1):127-34. doi: 10.1002/mus.23500. Epub 2012 Nov 21.

PMID:
23169582
18.

Long-term course of substantia nigra hyperechogenicity in Parkinson's disease.

Behnke S, Runkel A, Kassar HA, Ortmann M, Guidez D, Dillmann U, Fassbender K, Spiegel J.

Mov Disord. 2013 Apr;28(4):455-9. doi: 10.1002/mds.25193. Epub 2012 Oct 31.

PMID:
23115064
19.

Response of Toll-like receptors in experimental Guillain-Barré syndrome: a kinetic analysis.

Gries M, Davies L, Liu Y, Bachhuber A, Spiegel J, Dillmann U, Hartmann T, Fassbender K, Walter S.

Neurosci Lett. 2012 Jun 19;518(2):154-60. doi: 10.1016/j.neulet.2012.04.077. Epub 2012 May 8.

PMID:
22579825
20.

Adult manifestation of L-2-hydroxyglutarate dehydrogenase deficiency by a novel mutation.

Sühs KW, Erdmann P, Shamdeen MG, Papanagiotou P, Dillmann U.

Neurology. 2012 Apr 10;78(15):1186-7. doi: 10.1212/WNL.0b013e31824f8033. Epub 2012 Mar 28. No abstract available.

PMID:
22459673
21.

Parkinson's disease risk score: moving to a premotor diagnosis.

Winkler J, Ehret R, Büttner T, Dillmann U, Fogel W, Sabolek M, Winkelmann J, Kassubek J.

J Neurol. 2011 May;258(Suppl 2):S311-5. doi: 10.1007/s00415-011-5952-x. Review.

PMID:
21560061
22.

[Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].

Bürmann J, Fassbender K, Henn W, Lohse P, Holzhoffer C, Fassbender K, Dillmann U.

Fortschr Neurol Psychiatr. 2011 Apr;79(4):238-41. doi: 10.1055/s-0029-1246083. Epub 2011 Apr 8. German.

PMID:
21480154
23.

Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's disease.

Dorschner J, Farmakis G, Behnke S, Hellwig D, Schneider S, Fassbender K, Kirsch CM, Dillmann U, Spiegel J.

Parkinsonism Relat Disord. 2011 Jun;17(5):372-5. doi: 10.1016/j.parkreldis.2011.03.001. Epub 2011 Mar 21.

PMID:
21421334
24.

FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's disease.

Hubbuch M, Farmakis G, Schaefer A, Behnke S, Schneider S, Hellwig D, Fassbender K, Kirsch CM, Dillmann U, Spiegel J.

Eur Neurol. 2011;65(4):187-92. doi: 10.1159/000324732. Epub 2011 Mar 11.

PMID:
21412004
25.

Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner--results from a longitudinal study on 500 subjects.

Wollenweber FA, Schomburg R, Probst M, Schneider V, Hiry T, Ochsenfeld A, Mueller M, Dillmann U, Fassbender K, Behnke S.

Psychiatry Res. 2011 Mar 31;191(3):212-6. doi: 10.1016/j.pscychresns.2010.09.010. Epub 2011 Feb 2.

PMID:
21288698
26.

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.

Berg D, Seppi K, Liepelt I, Schweitzer K, Wollenweber F, Wolf B, Dillmann U, Stockner H, Godau J, Kiechl S, Gaenslen A, Willeit J, Di Santo A, Maetzler W, Gasser T, Poewe W, Behnke S.

Mov Disord. 2010 Jul 30;25(10):1464-9. doi: 10.1002/mds.23114.

PMID:
20629151
27.

[Early deep brain stimulation for Parkinson's disease].

Schnitzler A, Fuchs G, Baas H, Dillmann U, Hilker R, Oechsner M.

Fortschr Neurol Psychiatr. 2010 Mar;78 Suppl 1:S37-40. doi: 10.1055/s-0029-1245159. Epub 2010 Mar 1. Review. German.

PMID:
20195941
28.

Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.

Liepelt I, Behnke S, Schweitzer K, Wolf B, Godau J, Wollenweber F, Dillmann U, Gaenslen A, Di Santo A, Maetzler W, Berg D.

Neurobiol Aging. 2011 Sep;32(9):1599-606. doi: 10.1016/j.neurobiolaging.2009.10.004. Epub 2009 Nov 7.

PMID:
19897277
29.

Methylation status and neurodegenerative markers in Parkinson disease.

Obeid R, Schadt A, Dillmann U, Kostopoulos P, Fassbender K, Herrmann W.

Clin Chem. 2009 Oct;55(10):1852-60. doi: 10.1373/clinchem.2009.125021. Epub 2009 Aug 13.

30.

Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET.

Behnke S, Schroeder U, Dillmann U, Buchholz HG, Schreckenberger M, Fuss G, Reith W, Berg D, Krick CM.

Neuroimage. 2009 Oct 1;47(4):1237-43. doi: 10.1016/j.neuroimage.2009.05.072. Epub 2009 Jun 1.

PMID:
19497378
31.

A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy.

Jonckheere AI, Hogeveen M, Nijtmans L, van den Brand M, Janssen A, Diepstra H, van den Brandt F, van den Heuvel B, Hol F, Hofste T, Kapusta L, Dillmann U, Shamdeen M, Smeitink J, Smeitink J, Rodenburg R.

BMJ Case Rep. 2009;2009. pii: bcr07.2008.0504. doi: 10.1136/bcr.07.2008.0504. Epub 2009 Jan 23.

32.

Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson's Disease.

Spiegel J, Hellwig D, Jost WH, Farmakis G, Samnick S, Fassbender K, Kirsch CM, Dillmann U.

Open Neurol J. 2007;1:1-4. doi: 10.2174/1874205X00701010001. Epub 2007 Aug 22.

33.

Frequency and treatment of depressive symptoms in a Parkinson's disease registry.

Althaus A, Becker OA, Spottke A, Dengler R, Schneider F, Kloss M, Eggert K, Oertel WH, Dillmann U, Herting B, Classen J, Dodel R.

Parkinsonism Relat Disord. 2008 Dec;14(8):626-32. doi: 10.1016/j.parkreldis.2008.01.016. Epub 2008 Apr 11.

PMID:
18406197
34.

A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy.

Jonckheere AI, Hogeveen M, Nijtmans LG, van den Brand MA, Janssen AJ, Diepstra JH, van den Brandt FC, van den Heuvel LP, Hol FA, Hofste TG, Kapusta L, Dillmann U, Shamdeen MG, Smeitink JA, Rodenburg RJ.

J Med Genet. 2008 Mar;45(3):129-33. Epub 2007 Oct 22.

PMID:
17954552
36.

Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.

Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K, Kirsch CM, Dillmann U.

Mov Disord. 2007 May 15;22(7):1004-8.

PMID:
17427942
37.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section.

N Engl J Med. 2006 Aug 31;355(9):896-908. Erratum in: N Engl J Med. 2006 Sep 21;355(12):1289.

38.

Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.

Spiegel J, Hellwig D, Samnick S, Jost W, Möllers MO, Fassbender K, Kirsch CM, Dillmann U.

J Neural Transm (Vienna). 2007 Mar;114(3):331-5. Epub 2006 May 24.

PMID:
16715205
39.

Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.

Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJ, Duran M, Marziniak M.

Am J Hum Genet. 2006 Jun;78(6):1046-52. Epub 2006 Mar 29.

40.

Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.

Spiegel J, Hellwig D, Möllers MO, Behnke S, Jost W, Fassbender K, Samnick S, Dillmann U, Becker G, Kirsch CM.

Brain. 2006 May;129(Pt 5):1188-93. Epub 2006 Mar 2.

PMID:
16513685
41.

Orthostatic tremor during modification of standing.

Spiegel J, Krick C, Fuss G, Sood D, Becker G, Dillmann U.

Mov Disord. 2006 Feb;21(2):173-8.

PMID:
16149097
42.

Is primary orthostatic tremor associated with an autochthonous immunoglobulin synthesis in the cerebrospinal fluid?

Spiegel J, Fuss G, Dillmann U.

Mov Disord. 2005 Aug;20(8):1079-80. No abstract available.

PMID:
16007656
43.

[The 10-minute office visit. Differential diagnosis of tremor. The hands shake -- Parkinson?].

Dillmann U, Spiegel J.

MMW Fortschr Med. 2005 May 5;147(18):59-60. German. No abstract available.

PMID:
15934595
44.

FP-CIT and MIBG scintigraphy in early Parkinson's disease.

Spiegel J, Möllers MO, Jost WH, Fuss G, Samnick S, Dillmann U, Becker G, Kirsch CM.

Mov Disord. 2005 May;20(5):552-61.

PMID:
15645531
45.

Improvement of upper limb ataxia and intention tremor allowing cessation of thalamic electrostimulation after four years.

Moringlane JR, Spiegel J, Fuss G, Dillmann U, Pützer M, Sittinger H.

Mult Scler. 2004 Dec;10(6):708-10.

PMID:
15584498
46.

Echogenic substantia nigra in patients with orthostatic tremor.

Spiegel J, Behnke S, Fuss G, Becker G, Dillmann U.

J Neural Transm (Vienna). 2005 Jul;112(7):915-20. Epub 2004 Nov 3.

PMID:
15526141
47.

Improvement of apraxia of lid opening by STN-stimulation in a 70-year-old patient with Parkinson's disease. A case report.

Fuss G, Spiegel J, Magnus T, Moringlane JR, Becker G, Dillmann U.

Minim Invasive Neurosurg. 2004 Feb;47(1):58-60.

PMID:
15100935
48.

Impact of different stimulation types on orthostatic tremor.

Spiegel J, Fuss G, Krick C, Dillmann U.

Clin Neurophysiol. 2004 Mar;115(3):569-75.

PMID:
15036052
49.

Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report.

Spiegel J, Fuss G, Backens M, Reith W, Magnus T, Becker G, Moringlane JR, Dillmann U.

J Neurosurg. 2003 Oct;99(4):772-4.

PMID:
14567615
50.

[Effect of deep brain stimulation on glottal phonation in patients with Parkinson's disease and multiple sclerosis].

Pützer M, Barry WJ, Moringlane JR, Fuss G, Spiegel J, Dillmann U, Sittinger H.

Folia Phoniatr Logop. 2003 Sep-Oct;55(5):220-32. German.

PMID:
12931056

Supplemental Content

Loading ...
Support Center